US Broker Ratings

SS Innovations International (SSII) Stock Analysis: Examining an Impressive 192.5% Revenue Growth in the Medical Device Sector

SS Innovations International Inc. (SSII), a burgeoning force in the healthcare sector, operates in the medical devices industry, showcasing revolutionary advancements in surgical robotics. Headquartered in Gurugram, India, the company..

Disc Medicine, Inc. (IRON) Stock Analysis: Evaluating a 66% Upside Potential in Biotechnology

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline of treatments aimed at serious hematologic diseases. Headquartered in Watertown, Massachusetts,..

Kestra Medical Technologies (KMTS) Investor Outlook: 53% Revenue Surge and 8% Upside Potential

Investors looking for opportunities in the healthcare sector might want to pay close attention to Kestra Medical Technologies, Ltd. (KMTS). This innovative company, headquartered in Kirkland, Washington, is making waves..

Privia Health Group, Inc. (PRVA) Investor Outlook: Unpacking a 44.48% Potential Upside in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent name in the healthcare sector, is capturing investor attention with a striking potential upside of 44.48%. Operating as a physician-enablement company, Privia..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 54.7% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV), a key player in the healthcare sector, offers a compelling opportunity for investors looking to tap into the Medicare Advantage market. With a market..

PTC Therapeutics, Inc. (PTCT) Investor Outlook: Exploring a 19% Potential Upside

In the ever-evolving landscape of biotechnology, PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out as a key player with a focus on rare disorders. Headquartered in Warren, New Jersey, PTC Therapeutics..

Addus HomeCare Corporation (ADUS) Stock Analysis: 35.96% Upside Potential Sparks Investor Interest

Addus HomeCare Corporation (NASDAQ: ADUS) stands out as a compelling opportunity in the healthcare sector, particularly within the medical care facilities industry. With a current market capitalization of $1.92 billion,..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: With a Potential Upside of 243.92%, Is This Healthcare Stock a Hidden Gem?

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnology company renowned for its innovation in developing therapeutics for rare diseases, presents a compelling opportunity for investors seeking high-growth potential within the healthcare..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Evaluating a 24.68% Potential Upside for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling investment opportunity, especially for those looking to capitalize on its robust position in the healthcare sector. With a significant market cap..

Catalyst Pharmaceuticals (CPRX) Investor Outlook: A Promising 41.4% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing the attention of individual investors with its compelling investment proposition. This biopharmaceutical company, headquartered in Coral Gables, Florida, focuses on developing and commercializing..

BioLife Solutions (BLFS): Investor Outlook on a Healthcare Innovator With a 43% Potential Upside

Investors with an eye on the healthcare sector may find BioLife Solutions, Inc. (NASDAQ: BLFS) an intriguing opportunity. As a key player in the Medical Instruments & Supplies industry, BioLife..

Select Medical Holdings Corp (SEM): Analyst Consensus Indicates 17.65% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM), a prominent player in the healthcare sector, is positioned for intriguing growth potential. With a market capitalization of $1.94 billion, the company has carved..

Bausch Health Companies Inc. (BHC) Stock Analysis: Robust Free Cash Flow and Potential 24% Upside

Bausch Health Companies Inc. (NYSE: BHC) offers investors a unique proposition within the healthcare sector, particularly in the drug manufacturing industry. With its diversified portfolio spanning gastroenterology, neurology, dermatology, and..

Establishment Labs Holdings Inc (ESTA): Investor Outlook on a Healthcare Innovator with 19.77% Upside Potential

For investors seeking exposure to the burgeoning medical devices sector, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents an intriguing opportunity. Headquartered in Alajuela, Costa Rica, this healthcare company specializes in..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 41% Upside Potential Amidst Healthcare Innovations

Investors with an eye on the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) an intriguing opportunity. This specialty pharmaceutical company, headquartered in Brisbane, California, stands at the forefront..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising 18.12% Upside Potential for Investors

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is capturing the attention of investors with its robust potential for growth in the biopharmaceutical sector, particularly in dermatological treatments. With a market capitalization of..

Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 93% Upside Potential in Healthcare

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is capturing the attention of investors with its significant upside potential. As a medical care facilities company headquartered in..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a 115% Potential Upside in the Biotech Arena

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial potential upside. Headquartered in Hampton, New Jersey, this..

Mesoblast Limited (MESO) Stock Analysis: Exploring a Promising 108.58% Upside Potential

For investors with an eye on the biotechnology sector, Mesoblast Limited (NASDAQ: MESO) presents a compelling opportunity. With its focus on regenerative medicine, this Australian company is at the forefront..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 50% Potential Upside for Investors

Innoviva, Inc. (NASDAQ: INVA), firmly positioned in the biotechnology sector, presents an intriguing opportunity for investors seeking a blend of growth potential and strategic pharmaceutical innovations. With a robust market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds